...
首页> 外文期刊>Ophthalmology >Surgical management of rhegmatogenous retinal detachment: A meta-analysis of randomized controlled trials
【24h】

Surgical management of rhegmatogenous retinal detachment: A meta-analysis of randomized controlled trials

机译:孔源性视网膜脱离的外科治疗:随机对照试验的荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To examine possible differences in clinical outcomes between pars plana vitrectomy (PPV) and scleral buckling (SB) for uncomplicated rhegmatogenous retinal detachment (RRD). Design: Meta-analysis. Participants: Adult patients with uncomplicated RRD from previously reported randomized controlled trials of PPV and SB. Methods: A comprehensive literature search using the Cochrane Collaboration methodology to identify randomized controlled trials comparing PPV with SB for uncomplicated RRD. Main Outcome Measures: Analysis was divided into phakic and pseudophakic/aphakic patients. Primary outcome parameters included proportion of primary reattachment and difference of means of best-corrected visual acuity (BCVA) at 6 months or more between the PPV and SB groups. Secondary outcome parameters included the proportion of secondary reattachment and complications between the PPV and SB groups. Results: Seven studies were identified and analyzed for comparing PPV (636 eyes) with SB (670 eyes) for uncomplicated RRD. In the phakic group, there were no significant differences in the proportion of primary reattachments (odds ratio [OR], 1.00; 95% confidence interval [CI], 0.69-1.46) or secondary reattachments (OR, 0.99; 95% CI, 0.34-2.87) between the PPV and SB groups. Meta-analysis showed a statistically significant difference in the logarithm of the minimum angle of resolution (logMAR) BCVA at 6 months between the PPV-treated and SB-treated phakic eyes (mean deviation, 0.14; 95% CI, 0.06-0.21; P<0.0004). In the pseudophakic/aphakic group, there were no significant differences in the proportion of primary reattachments (OR, 1.46; 95% CI, 0.79-2.71) or logMAR BCVA at 6 months between the PPV and SB groups (mean deviation, -0.03; 95% CI, -0.10 to 0.04). A statistically significant difference was noted in the proportion of secondary reattachments (OR, 2.08; 95% CI, 1.08-4.03; P = 0.03) between the PPV and SB groups in pseudophakic/aphakic eyes. Meta-analysis showed a statistically significant rate of cataract progression in the PPV group (OR, 4.11; 95% CI, 2.70-6.25; P<0.00001). Conclusions: There were no significant differences in the proportions of primary reattachment in the PPV and SB groups in phakic eyes. The SB-treated phakic eyes had better postoperative BCVA at 6 months or more. This is most likely related to higher rates of cataract progression in PPV-treated phakic eyes. There were no significant differences in proportions of primary reattachment and postoperative BCVA at 6 months or more in pseudophakic/aphakic eyes. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
机译:目的:探讨单纯性玻璃体切除术(PPV)和巩膜扣紧术(SB)在单纯性流源性视网膜脱离(RRD)之间临床结果的可能差异。设计:荟萃分析。参与者:先前报道的PPV和SB随机对照试验的未合并RRD的成年患者。方法:使用Cochrane协作方法进行全面的文献检索,以鉴定比较PPV与SB的RRD的随机对照试验。主要结果指标:分析分为有晶状体和假晶状体/无晶状体患者。主要结果参数包括PPV组和SB组之间6个月或更长时间的初次重新连接比例和最佳矫正视力(BCVA)的均值差异。次要结局参数包括PPV和SB组之间的二次再连接比例和并发症。结果:鉴定并分析了7项研究,比较了单纯性RRD的PPV(636眼)和SB(670眼)。在晶状体组中,初次再连接的比例(优势比[OR],1.00; 95%置信区间[CI],0.69-1.46)或二次再连接的比例(OR,0.99; 95%CI,0.34)没有显着差异-2.87)在PPV和SB组之间。荟萃分析显示,PPV治疗和SB治疗的有晶状体眼在6个月时的最小分辨角(logMAR)BCVA的对数具有统计学意义的差异(平均偏差,0.14; 95%CI,0.06-0.21; P <0.0004)。在伪晶状体/无晶状体组中,PPV组和SB组之间在6个月时初次再连接的比例(OR,1.46; 95%CI,0.79-2.71)或logMAR BCVA没有显着差异(平均偏差,-0.03; 95%CI,-0.10至0.04)。在伪晶状体/无晶状体眼中,PPV组和SB组之间的继发性再附着比例(OR,2.08; 95%CI,1.08-4.03; P = 0.03)在统计学上有显着差异。荟萃分析显示PPV组白内障进展具有统计学意义(OR,4.11; 95%CI,2.70-6.25; P <0.00001)。结论:有晶状体眼的PPV组和SB组的初次再附着比例没有显着差异。经SB治疗的有晶状体眼在术后6个月或更长时间具有更好的BCVA。这很可能与PPV治疗的有晶状体眼中白内障进展速度加快有关。在假晶状体/无晶状体眼中,六个月或更长时间的初次复位和术后BCVA的比例没有显着差异。财务披露:作者对本文讨论的任何材料均没有所有权或商业利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号